Feliza Mirasol is the science editor for 

Articles

India’s Enzene Biosciences is investing $50 Million into a new biopharma manufacturing plant in Hopewell, NJ.

Enzene Biosciences Invests $50 Million into New Jersey Biomanufacturing Facility

The transaction is expected to close in the third quarter of 2023.

Eli Lilly Set to Acquire DICE Therapeutics 

Researchers at the University of Waterloo have developed a liquid-liquid encapsulation system for use in sustainable encapsulation processes.

University of Waterloo Researchers Announce Sustainable Encapsulation Technology

Eli Lilly & Company will pay Verve Therapeutics up to $525 million to advance a lipoprotein gene editing research program.

Lilly Enters Gene Editing Collaboration with Verve Therapeutics

The new facility also provides a plan for scalable product production processes that can potentially be replicated by Vaxxas domestically and globally.

Vaxxas Opens Manufacturing Facility for Clinical Trials and Commercial Products

Podcasts

Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy. 

Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

There is concern that debates will delay the five-year reauthorization of PEPFAR under review by Congress.

Long-Admired PEPFAR Program Caught in Abortion Debate

Advanco’s acquisition of Vantage Consulting Group boosts its position as a provider of independent pharmaceutical serialization solutions.

Advanco Acquires Vantage Consulting Group

The collaboration between the Pistoia Alliance and Matador Japan will work to accelerate research and promote access to a global pharmaceutical ecosystem.

Pistoia Alliance and Matador Japan Collaborate to Accelerate Research

The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.

News